Helen of Troy Limited (HELE) Stock Forecast and Price Target (2026)

Last updated November 2026

Short answer

3 analysts covering Helen of Troy Limited (HELE) carry an average price target of $31.67 as of November 2026, -8.0% against the $34.44 share price on November 20, 2026. The published targets run from $26.00 to $40.00, a spread of 44% of the average, so the disagreement is moderate. The rating split is 1 buy, 3 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market. Walnut is not an investment adviser.

HELE analyst price targets

Price
$34.44
Average target
$31.67
Median target
$29.00
Implied vs price
-8.0%
Target range
$26.00 to $40.00
Analysts covering
3
Ratings
1 buy3 hold0 sell

HELE analyst data as of November 2026, sourced from Yahoo Finance and may be delayed. The price is the last one Yahoo Finance reported on November 20, 2026.A price target is what an analyst published on a date, not a forecast Walnut endorses, and targets are typically set on a 12-month view. Verify current figures before deciding.

The average target of $31.67 sits below the $34.44 price, -8.0%. The median is $29.00, and where the two differ the median is the steadier read, because one unusually high or low target cannot drag it.

What the HELE target range actually tells you

The published targets span $26.00 to $40.00. That gap is 44% of the average target, which counts as moderate disagreement. A spread like this is fairly typical: enough agreement that the average means something, enough disagreement that it should not be treated as precise.

The useful move is to read the high target as one bull scenario and the low target as one bear scenario, then ask which set of assumptions you find more plausible. Both cases are worked through on the HELE is it a buy page.

Recent analyst actions on HELE

FirmActionTargetPriorDate
UBSRaised (Neutral)$29.00$28.00October 9, 2026
Canaccord GenuityMaintained (Hold)$26.00$26.00October 9, 2026
Canaccord GenuityRaised (Hold)$26.00$25.00October 6, 2026
UBSRaised (Neutral)$28.00$25.00July 9, 2026
Canaccord GenuityRaised (Hold)$25.00$23.00July 9, 2026

The most recent published rating actions on HELE within the last six months, from Yahoo Finance. Each row is dated because a target only means something alongside the date it was set. Walnut is not an investment adviser and does not endorse any of these views.

In the last six months there have been 4 raises and 0 cuts among these actions. The direction of revisions is often more telling than the level, because it shows which way informed opinion is moving. Note the tension here: the average target sits below the current price, yet the recent individual actions have mostly been raises. That usually means the published average has not caught up with the most recent revisions, and it is a good reason not to lean on the average alone.

How analysts rate HELE

Of the analysts with a published rating, 1 say buy, 3 say hold, and 0 say sell, so 25% carry a buy. That mix has been broadly steady over the last three months.

The distribution says more than the label. Sell ratings are rare across the entire market for structural reasons, so a stock with no sell ratings is unremarkable, while even a handful of them is worth understanding.

Why a HELE price target is not a prediction

  • It is a 12-month model output. An analyst picks assumptions for revenue, margin, and a multiple, and the target falls out of the arithmetic. Change one assumption and the target moves a lot.
  • The distribution is skewed. Sell-side coverage carries far more buy ratings than sell ratings across the whole market, so the average is not a balanced vote.
  • Targets follow price as often as they lead it. Revisions frequently arrive after a move, not before, which is why a rising target is weak evidence on its own.
  • Nobody is scored on it. There is no cost to a target that never gets close, so treat accuracy as unverified unless you check the firm's record yourself.

HELE earnings and revenue forecast

For the fiscal year ending Feb 2027, the 4 analysts publishing estimates on HELE expect earnings of $3.89 per share (+9.6% on the year before) and revenue of $1.8 billion (+1.0%).

PeriodEPS estimateEPS growthRevenue estimateRevenue growth
Quarter ending Nov 2026
next quarter to report, 4 analysts
$2.25
$2.16 to $2.34
+32%$501 million
$496.4 million to $503.8 million
-2.3%
Quarter ending Feb 2027
the quarter after, 4 analysts
$0.66
$0.50 to $0.92
-20%$459.3 million
$453 million to $464.2 million
-2.3%
Fiscal year ending Feb 2027
fiscal year next to report, 4 analysts
$3.89
$3.80 to $4.04
+9.6%$1.8 billion+1.0%
Fiscal year ending Feb 2028
the fiscal year after, 4 analysts
$4.04
$3.90 to $4.23
+4.0%$1.8 billion
$1.8 billion to $1.9 billion
+1.5%

Consensus estimates for HELE published by sell-side analysts, as of November 2026, from Yahoo Finance. Each figure is the average of the analysts counted, with the lowest and highest estimate beneath it; growth compares with the same period a year earlier and is left blank where either figure is a loss. Estimates change constantly. Walnut is not an investment adviser.

Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level. Helen of Troy Limited next reports around January 7, 2027 (an estimated date), which is when these figures get tested against actual results.

What Helen of Troy Limited actually reported for Q2 fiscal 2027, line by line against the year before, is on the HELE earnings page.

Is there a 2030 forecast for HELE?

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering HELE do not put out a 2030 number. Anything presenting one is extrapolating a growth rate of its own, and a figure produced that way tells you about the assumption chosen, not about the company.

The furthest-out consensus that exists is for the fiscal year ending Feb 2028: analysts expect earnings of $4.04 per share, +4.0% on the fiscal year ending Feb 2027 estimate of $3.89. Beyond that, nobody publishes estimates, so any later number is an extrapolation.

What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.

For a ten-year question, that frame is more useful. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Helen of Troy Limited can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

What could move HELE from here

In short: the drivers cited most often are Leadership Brand portfolio, Cost restructuring and cash flow, Debt paydown and balance sheet. The risk cited most often against it is revenue growth is minimal (~2% year over year in the latest quarter) and Beauty & Wellness sales are still declining, so a sustained rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the HELE is it a buy page.

Your questions about Helen of Troy Limited

Ask Walnut's AI anything about HELE and see how it fits what you own.

FAQ

What is the price target for Helen of Troy Limited (HELE)?

+

The average analyst price target for HELE is $31.67 as of November 2026, across 3 analysts. The average is -8.0% against the $34.44 share price on November 20, 2026, so the consensus sits below where the stock trades. The median target, which is less distorted by one extreme view, is $29.00. Targets move constantly; verify the current figure before relying on it.

How high could HELE go?

+

The highest published target is $40.00, which is +16.1% against the $34.44 price. It is one analyst's most optimistic case, not a ceiling and not a forecast. The lowest is $26.00. The gap between them answers this question best: analysts who all follow Helen of Troy Limited closely disagree by 44% of the average target, so treat any single number as one scenario.

How many analysts cover HELE?

+

3 analysts publish estimates on HELE as of November 2026. Of those with a published rating, 1 say buy, 3 hold, and 0 sell, so 25% carry a buy rating. More coverage usually means the consensus is better informed, though it also means the obvious points are already in the price.

Are analyst price targets for HELE accurate?

+

Treat them as informed opinion, not measurement. Two things matter here. Sell-side ratings skew positive across the market, and HELE is no exception at 25% buy ratings, so the distribution is not a balanced vote. And targets tend to follow the share price at least as often as they lead it, getting raised after a stock has already run. They are most useful as a read on what the informed consensus expects, and least useful as a prediction of where the price lands.

Has the HELE price target been raised or cut recently?

+

In the last six months there have been 4 raises and 0 cuts among the published actions on HELE. The most recent was UBS, which raised its target to $29.00 from $28.00 on October 9, 2026. The direction of revisions often tells you more than the level, because it shows which way the informed view is moving.

What are analysts' earnings estimates for Helen of Troy Limited (HELE)?

+

For the fiscal year ending Feb 2027, the 4 analysts publishing estimates on HELE expect earnings of $3.89 per share (+9.6% on the year before) and revenue of $1.8 billion (+1.0%). For the fiscal year ending Feb 2028, the consensus is $4.04 per share, +4.0% on the year before. These are consensus estimates as of November 2026, the average of what the covering analysts publish, and they are revised constantly, especially around each earnings report. They describe expectations, not results.

When does HELE report earnings next?

+

Helen of Troy Limited's next earnings report is expected around January 7, 2027, a date estimated from its reporting history that the company has not yet confirmed. The report is when the estimates on this page get tested against actual results, which is why targets and estimates tend to move most in the days after it.

What is the HELE stock price prediction for 2030?

+

There is no published one. Analyst targets run to about twelve months and no firm covering HELE publishes a 2030 figure, so any site showing one has extrapolated a growth rate of its own. The answerable version of the question is what the current price already assumes about Helen of Troy Limited's earnings, which the forward multiple on this page sets out, and what would have to change for that to break.

Will HELE go up in 2026?

+

Nobody knows, including the analysts publishing targets. What the numbers on this page tell you is where informed opinion currently sits and how much it disagrees with itself, which is useful and different from a prediction. The risk most often cited against Helen of Troy Limited: Revenue growth is minimal (~2% year over year in the latest quarter) and Beauty & Wellness sales are still declining, so a sustained rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. Walnut is not an investment adviser.

Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a November 2026 data pull of published third-party research, are approximate, and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026, and every percentage against it on this page is measured from that price. Verify current figures with your broker before acting on them.

Forecasts for similar stocks